(Q45748181)

15 December 2017

title

A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group (English)

1 reference

15 December 2017

1 reference

1 reference

1 reference

10

Sette A

1 reference

15 December 2017

author name string

Heathcote J

1

1 reference

15 December 2017

McHutchison J

2

1 reference

15 December 2017

Lee S

3

1 reference

15 December 2017

Tong M

4

1 reference

15 December 2017

Benner K

5

1 reference

15 December 2017

Minuk G

6

1 reference

15 December 2017

Wright T

7

1 reference

15 December 2017

Fikes J

8

1 reference

15 December 2017

Livingston B

9

1 reference

15 December 2017

Chestnut R

11

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

15 December 2017

published in

Hepatology

1 reference

15 December 2017

volume

30

1 reference

15 December 2017

issue

2

1 reference

15 December 2017

page(s)

531-536

1 reference

15 December 2017

A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

Vertical Transmission of Hepatitis B Antigen in Taiwan

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

Postnatal infectivity of hepatitis B surface antigen-carrier mothers.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immunity transfer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

Double-blind, randomized controlled trial of interleukin-2 treatment of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300208

7 January 2021

Identifiers

DOI

10.1002/HEP.510300208

1 reference

15 December 2017

1 reference

15 December 2017